High Tech Pharm Co., Ltd. (KOSDAQ:106190)
South Korea
· Delayed Price · Currency is KRW 14,110
-40 (-0.28%)
At close: Mar 31, 2025, 3:30 PM KST
High Tech Pharm Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 77,513 | 76,772 | 102,947 | 73,287 | 74,462 | Upgrade
|
| Other Revenue | - | -0 | - | - | 0 | Upgrade
|
| Revenue | 77,513 | 76,772 | 102,947 | 73,287 | 74,462 | Upgrade
|
| Revenue Growth (YoY) | 0.97% | -25.43% | 40.47% | -1.58% | 18.07% | Upgrade
|
| Cost of Revenue | 58,032 | 63,938 | 95,177 | 70,216 | 73,155 | Upgrade
|
| Gross Profit | 19,481 | 12,834 | 7,770 | 3,071 | 1,308 | Upgrade
|
| Selling, General & Admin | 3,790 | 2,601 | 2,705 | 3,310 | 4,551 | Upgrade
|
| Other Operating Expenses | 59.44 | 61.83 | 47.33 | 115.54 | 30.1 | Upgrade
|
| Operating Expenses | 3,923 | 2,745 | 2,843 | 3,483 | 4,631 | Upgrade
|
| Operating Income | 15,558 | 10,089 | 4,927 | -412.02 | -3,324 | Upgrade
|
| Interest Expense | -787.27 | -896.47 | -463.69 | -252.07 | -327.02 | Upgrade
|
| Interest & Investment Income | 8 | 4.69 | 4.31 | 84.73 | 96.39 | Upgrade
|
| Currency Exchange Gain (Loss) | 1,871 | 278.34 | -829.89 | -290.52 | 493.51 | Upgrade
|
| Other Non Operating Income (Expenses) | 307.37 | 282.41 | 267.28 | 1.82 | 466.46 | Upgrade
|
| EBT Excluding Unusual Items | 16,957 | 9,758 | 3,905 | -868.07 | -2,595 | Upgrade
|
| Gain (Loss) on Sale of Investments | 129.57 | 115.56 | 54.65 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -9.51 | 68.11 | 0.14 | -5 | Upgrade
|
| Pretax Income | 17,087 | 9,864 | 4,028 | -867.94 | -2,600 | Upgrade
|
| Income Tax Expense | 3,377 | 1,787 | -1,845 | 357.46 | 552.52 | Upgrade
|
| Net Income | 13,710 | 8,076 | 5,873 | -1,225 | -3,152 | Upgrade
|
| Net Income to Common | 13,710 | 8,076 | 5,873 | -1,225 | -3,152 | Upgrade
|
| Net Income Growth | 69.75% | 37.52% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | Upgrade
|
| Shares Change (YoY) | 0.09% | -0.06% | 0.08% | - | -0.08% | Upgrade
|
| EPS (Basic) | 1289.00 | 760.00 | 552.32 | -115.33 | -296.67 | Upgrade
|
| EPS (Diluted) | 1289.00 | 760.00 | 552.32 | -115.33 | -296.67 | Upgrade
|
| EPS Growth | 69.60% | 37.60% | - | - | - | Upgrade
|
| Free Cash Flow | 12,558 | -2,183 | -4,359 | 6,068 | -8,628 | Upgrade
|
| Free Cash Flow Per Share | 1180.71 | -205.38 | -409.94 | 571.13 | -812.06 | Upgrade
|
| Gross Margin | 25.13% | 16.72% | 7.55% | 4.19% | 1.76% | Upgrade
|
| Operating Margin | 20.07% | 13.14% | 4.79% | -0.56% | -4.46% | Upgrade
|
| Profit Margin | 17.69% | 10.52% | 5.71% | -1.67% | -4.23% | Upgrade
|
| Free Cash Flow Margin | 16.20% | -2.84% | -4.23% | 8.28% | -11.59% | Upgrade
|
| EBITDA | 20,727 | 15,075 | 10,472 | 5,139 | 2,128 | Upgrade
|
| EBITDA Margin | 26.74% | 19.64% | 10.17% | 7.01% | 2.86% | Upgrade
|
| D&A For EBITDA | 5,169 | 4,986 | 5,545 | 5,551 | 5,452 | Upgrade
|
| EBIT | 15,558 | 10,089 | 4,927 | -412.02 | -3,324 | Upgrade
|
| EBIT Margin | 20.07% | 13.14% | 4.79% | -0.56% | -4.46% | Upgrade
|
| Effective Tax Rate | 19.76% | 18.12% | - | - | - | Upgrade
|
| Advertising Expenses | 192.85 | 97.61 | 84.51 | 13.86 | 26.59 | Upgrade
|
Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.